Central Valley Advisors’s Merck MRK Stock Holding History

Central Valley Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Buy	2,648 +5	+0.2%	+$585	0.09%	146
2026 Q1	$318K	Sell	2,643 -22,304	-89%	-$2.57M	0.09%	143
2025 Q4	$2.63M	Buy	24,947 +1,084	+5%	+$102K	0.78%	39
2025 Q3	$2M	Buy	23,863 +702	+3%	+$57.8K	0.62%	47
2025 Q2	$1.83M	Buy	23,161 +3,312	+17%	+$263K	0.62%	46
2025 Q1	$1.78M	Buy	19,849 +964	+5%	+$90K	0.68%	43
2024 Q4	$1.88M	Buy	18,885 +1,471	+8%	+$152K	0.85%	31
2024 Q3	$1.98M	Buy	17,414 +498	+3%	+$59.2K	1.12%	24
2024 Q2	$2.34M	Buy	16,916 +335	+2%	+$43.2K	1%	27
2024 Q1	$2.19M	Buy	16,581 +722	+5%	+$89K	1.13%	22
2023 Q4	$1.73M	Buy	+15,859	New	+$1.65M	1.02%	22

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Central Valley Advisors's MRK Position: Q2 2026 in Review

Central Valley Advisors increased its Merck (MRK) stake by 0.19% in Q2 2026, buying an estimated $585 and bringing the position to 2,648 shares worth $340K. The position accounts for 0.09% of the portfolio, ranked #146.

Central Valley Advisors first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.63M in Q4 2025. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Central Valley Advisors held 2,648 shares of Merck worth $340K as of Q2 2026.
Central Valley Advisors bought 5 Merck shares in Q2 2026, an estimated $585.
Merck made up 0.09% of Central Valley Advisors's portfolio in Q2 2026, its #146 holding.
Central Valley Advisors first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
Central Valley Advisors's Merck position peaked at $2.63M in Q4 2025.
1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Central Valley Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.